Form 8-K - Current report:
SEC Accession No. 0000950170-24-114214
Filing Date
2024-10-11
Accepted
2024-10-11 08:00:08
Documents
12
Period of Report
2024-10-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bior-20241009.htm   iXBRL 8-K 65365
2 EX-3.1 bior-ex3_1.htm EX-3.1 19291
  Complete submission text file 0000950170-24-114214.txt   218862

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20241009.xsd EX-101.SCH 32529
14 EXTRACTED XBRL INSTANCE DOCUMENT bior-20241009_htm.xml XML 5079
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241366431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)